Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Geraniol synthase is a plant-derived enzyme, primarily classified as a monoterpene synthase, that catalyzes the conversion of geranyl diphosphate (GPP) to geraniol (EC 3.1.7.11) [1][2]. This enzyme is integral to the specialized metabolism of various aromatic plants, such as Ocimum basilicum (basil) and Vitis vinifera (grape), where it contributes to the production of floral scents and chemical defenses against herbivores and pathogens [3]. Although it is not a direct therapeutic target in humans, geraniol synthase is a major focus in metabolic engineering and synthetic biology for the sustainable production of geraniol [4]. Geraniol itself is a high-value compound used extensively in the flavor and fragrance industries and has shown potential pharmacological activities, including antimicrobial, anti-inflammatory, and antioxidant effects [5]. Consequently, research into geraniol synthase often targets the optimization of enzyme kinetics and expression levels in microbial hosts like yeast or E. coli for industrial-scale biosynthesis of terpenoid precursors [4]. [1] https://enzyme.expasy.org/EC/3.1.7.11 [2] https://www.uniprot.org/uniprotkb/P0C1N1/entry [3] https://pubmed.ncbi.nlm.nih.gov/15516502/ [4] https://pubmed.ncbi.nlm.nih.gov/24555464/ [5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011943/
Catalyzes the metal-dependent ionization and hydrolysis of geranyl diphosphate into geraniol and inorganic pyrophosphate [1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Geraniol synthase (GES).